MIH
AMGN icon

Meitav Investment House’s Amgen AMGN Stock Holding History

Meitav Investment House’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-204
Closed -$45K – 341
2023
Q2 		$45K Buy
+204
New +$47.3K ﹤0.01% 449
2021
Q2 		– Sell
-1,204
Closed -$301 – 413
2021
Q1 		$301 Sell
1,204
-560
-32% -$134K 0.01% 325
2020
Q4 		$401K Buy
+1,764
New +$407K 0.02% 307

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Meitav Investment House's AMGN Position: Q3 2023 in Review

Meitav Investment House sold out of Amgen (AMGN) in Q3 2023, closing a stake of 204 shares — an estimated $45K sold.

Meitav Investment House first reported a position in AMGN in Q4 2020 and held it in 3 quarters. The position peaked at $401K in Q4 2020. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • Meitav Investment House reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
  • Meitav Investment House sold 204 Amgen shares in Q3 2023, an estimated $45K.
  • Meitav Investment House first reported a position in Amgen in Q4 2020 and held it in 3 quarters.
  • Meitav Investment House's Amgen position peaked at $401K in Q4 2020.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Meitav Investment House's 13F filing for Q3 2023, filed 30 Oct 2023.